The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial

BACKGROUND: We performed a multicenter, randomized open-label trial in patients with moderate to severe Covid-19 treated with a range of possible treatment regimens. Methods: Patients were randomly assigned to one of three regimen groups at a ratio of 1:1:1. The primary outcome of this study was adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanei, Mostafa, Solaymani-Dodaran, Masoud, Qazvini, Ali, Ghazale, Amir Hosein, Setarehdan, Seyed Amin, Saadat, Seyed Hassan, Ghobadi, Hassan, Hoseininia, Saeed, Elahikhah, Maryam, Samadi, Ali Hossein, Imani, Yousef, Vahedi, Ensieh, Babamahmoodi, Farhang, Rostami, Fatemeh Tajik, Ardebili, Mohammad Hossein Azimzadeh, Ansarifar, Akram, Golmaei, Fatemeh Fallahpoor, Asadollah, Atieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441037/
https://www.ncbi.nlm.nih.gov/pubmed/34526033
http://dx.doi.org/10.1186/s12931-021-01833-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441037/
https://www.ncbi.nlm.nih.gov/pubmed/34526033
http://dx.doi.org/10.1186/s12931-021-01833-6

Ejemplares similares